Making Sense of Semaglutide in Type 1 Diabetes

In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and their real-world experiences with GLP-1 use in people with type 1 diabetes.

Video version: https://www.hcplive.com/view/diabetes-dialogue-making-sense-of-semaglutide-in-type-1-diabetes